Barclays »

Armata Pharmaceuticals shares owned by Barclays

Quarter-by-quarter ownership of Armata Pharmaceuticals (ARMP) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Armata Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Armata Pharmaceuticals held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Armata Pharmaceuticals by Barclays

Quarter filed Position value Share count Share price at filing
2025-09-30 $18 6 3.00

More positions owned by Barclays

Microsoft Corporation (MSFT)
SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Fund (QQQ)
NVIDIA Corporation (NVDA)
Ishares Tr Fund (IWM)
Apple (AAPL)
Tesla Opt Put Option (TSLA)
Amazon Opt Call Option (AMZN)
Alphabet Opt Call Option (GOOGL)
Broadcom Opt Call Option (AVGO)
Facebook Inc cl a (META)
Ishares Tr Opt Call Option (HYG)
JPMorgan Chase & Co. (JPM)
Alphabet Opt Put Option (GOOG)
Berkshire Hathaway Inc Del Opt Put Option (BRK.B)

View all positions for Barclays

Top funds holding Armata Pharmaceuticals

Vanguard Group
Geode Capital Management
Edgewood Management
Bridgeway Capital Management
Renaissance Technologies
State Street Corporation
SeaCrest Wealth Management
GSB Wealth Management
BlackRock
Northern Trust
Captrust Financial Advisors
Group One Trading
Measured Wealth Private Client Group
Trifecta Capital Advisors
Northwestern Mutual Wealth Management Company

View all funds holding Armata Pharmaceuticals